Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial

Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial

The maximum tolerated dose (MTD) of lobaplatin as a single agent chemotherapy concurrent with intensity-modulated radiotherapy (IMRT) in Asian population with nasopharyngeal carcinoma (NPC) remains unclear. From June 2016 to December 2017, 17 patients diagnosed with stage III-IVb NPC from an Asian p...

Full description

Bibliographic Details
Main Authors: Si-Yang Wang, Xi-Wei Xu, Ji-Jin Yao, Pei-Jian Peng, Bin Zhou, Qiao-Dan Liu, Xiao-Ping Huang, Zhong Lin
Format: Article
Language:English
Published: Elsevier 2018-08-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523318301852

Internet

http://www.sciencedirect.com/science/article/pii/S1936523318301852

Similar Items